Growth Metrics

Biogen (BIIB) Construction in Progress (2016 - 2025)

Biogen has reported Construction in Progress over the past 17 years, most recently at $163.1 million for Q4 2025.

  • For Q4 2025, Construction in Progress fell 47.11% year-over-year to $163.1 million; the TTM value through Dec 2025 reached $163.1 million, down 47.11%, while the annual FY2025 figure was $163.1 million, 47.11% down from the prior year.
  • Construction in Progress for Q4 2025 was $163.1 million at Biogen, down from $308.4 million in the prior quarter.
  • Over five years, Construction in Progress peaked at $1.9 billion in Q1 2021 and troughed at $163.1 million in Q4 2025.
  • A 5-year average of $754.1 million and a median of $711.1 million in 2022 define the central range for Construction in Progress.
  • Biggest five-year swings in Construction in Progress: rose 15.38% in 2022 and later crashed 68.38% in 2024.
  • Year by year, Construction in Progress stood at $770.3 million in 2021, then increased by 15.38% to $888.8 million in 2022, then increased by 9.74% to $975.4 million in 2023, then crashed by 68.38% to $308.4 million in 2024, then crashed by 47.11% to $163.1 million in 2025.
  • Business Quant data shows Construction in Progress for BIIB at $163.1 million in Q4 2025, $308.4 million in Q4 2024, and $975.4 million in Q4 2023.